Low-Risk Prostate CA Patients May Not Be Monitored Properly

This article originally appeared here.
Share this content:
Low-Risk Prostate CA Patients May Not Be Monitored Properly
Low-Risk Prostate CA Patients May Not Be Monitored Properly

FRIDAY, Dec. 4, 2015 (HealthDay News) -- Many men with low-risk prostate cancer who choose active surveillance may not be followed as closely as they should be, according to a study published in the Dec. 1 issue of Cancer.

The study included 37,687 men who were diagnosed with prostate cancer between 2004 and 2007, and followed through 2009.

The researchers found that patients who were undergoing watchful waiting/active surveillance were less likely to receive prostate-specific antigen testing and to attend office visits within the two years after diagnosis compared with patients who were receiving active treatment. Of the 3,626 men who chose watchful waiting/active surveillance instead of treatment such as surgery and radiation, only 4.5 percent were actually receiving active surveillance according to the authors' a priori definition.

"Many researchers have been advocating for active surveillance for men with low-risk disease," Chamie Karim Chamie, M.D., an assistant professor of urology at the University of California, Los Angeles, said in a university news release. "However, this study suggests that before we advise our patients to pursue active surveillance for their prostate cancers, we should be certain that we are committed to closely monitoring the cancers with a repeat biopsy, prostate-specific antigen testing, and physical exams."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Ground Beef Recalled After E. Coli Outbreak

Ground Beef Recalled After <i>E. Coli</i> Outbreak

Beef was produced and packaged at Cargill Meat Solutions in Fort Morgan, Colo.

Prevalence of Alzheimer's, Related Dementia Set to Double

Prevalence of Alzheimer's, Related Dementia Set to Double

Alzheimer's disease and related dementias burden is expected to increase to 3.3 percent in 2060

Long-Term Outcomes of Breast Implants Explored

Long-Term Outcomes of Breast Implants Explored

Higher rates of Sjogren syndrome, scleroderma, RA, stillbirth, melanoma for silicone implants

is free, fast, and customized just for you!




Already a member?

Sign In Now »